Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aprea Therapeutics Common stock (APRE) Q4 2024 Earnings
APRE
7
Nov
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.92
-0.81
-0.69
-0.58
Details
Expected EPS
-0.716433
Actual EPS
-0.64
Surprise EPS
0.08
Surprise Percent
+10.67%
Description
Aprea Therapeutics Common stock (APRE) has reported earnings of -0.64 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login